1.16 - Prof David Nutt: The Neuroscience Of Psychedelics, Addiction, And How Drugs Help Us Understand The Brain Mind Medicine Australia

Prof David Nutt is Neuropsychopharmacologist specialising in the research of drugs that affect the brain and conditions such as addiction, anxiety, and sleep.
David is the chairman of Drug Science, a non-profit which he founded in 2010 to provide independent, evidence-based information on drugs. Nutt is the deputy head of the Centre for Psychedelic Research at Imperial College London. He and his team have published research into psilocybin for TRD, as well as neuroimaging studies investigating psilocybin, MDMA, LSD, and DMT.
In this episode:
How drugs help our understanding of the brainImpact of prohibition on investigation and researchKey terms - decriminalisation, depenalisation, legalisationDrug harm profiles - alcohol, lsd, mdma, psilocybinPhysiology and psychology of addictionBrain-mind interplayThe psychedelic experience and its phenomena The default mode networkFunctional connectivityNeuroplasticityWhy profound alterations in consciousness permit long-term changesSerotonin's role in depressionPsilocybin vs SSRIs and the 5HT2a receptorPsychedelics vs Psychedelic-assisted psychotherapies 
Links:
Drug Science
The Drug Science Podcast
David Nutt on Twitter
Recent paper exploring Psilocybin vs SSRIs:
Serotonin and brain function: a tale of two receptors
Support the podcast:
Support the podcast (Patreon)
Support the mission:
Mind Medicine Australia
Donate to Mind Medicine Australia
Join a local chapter
Support this show http://supporter.acast.com/mind-medicine-australia.
Become a member at https://plus.acast.com/s/mind-medicine-australia.



Hosted on Acast. See acast.com/privacy for more information.